Tools and Guidelines

Displaying results 1 - 10 of 394

Resource | Guidelines
These guidelines focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer-term health care – building upon 2017 and 2020 strategic information guidelines. The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing and treatment, and linkages to services for sexually transmitted infections, viral hepatitis, tuberculosis and cervical cancer. The guidelines also cover the use of routinely collected data for HIV surveillance (including measurement of HIV prevalence and incidence) and emphasize the use of data from different sources to gain a better picture of epidemiologic trends.
 
 
Resource | Guidelines
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination’ while delivering quality services for women, girls and their children, through the life-course, respecting human rights and ensuring gender equality and community engagement.  This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.
 
 
Resource | Guidelines
It cannot be stressed enough that violence against women and girls continues to be one of the most pervasive human rights violations in the world. It acts as both a cause and a consequence of gender inequality, and ranges in impact from adverse effects on the health, safety, productivity and overall well-being of women and girls, to impeding the realization of their rights and contribution to society at large. Despite decades of concerted efforts, at the global, regional and local levels.
 
 
Resource | Tools
This compendium is designed to help National TB Programmes (NTPs) to make best use of the available tools for policy, planning and programmatic action. The document summarizes information about the key tools related to data and evidence that are available for use in TB planning and programming, and how they can be applied. The tools that are profiled are described in terms of how they fit within the People-centred framework for tuberculosis programme planning and prioritization. Together with the people-centred framework, this compendium aims to enable better use of data and evidence for TB programme planning at both the national and subnational levels. It is designed to help NTPs and their national stakeholders to understand how and when different data and evidence-related tools could be used.
 
 
Resource | Guidelines
Voluntary medical male circumcision (VMMC) has been recommended by WHO and UNAIDS since 2007, and was re-evaluated in 2020 as an effective intervention for the prevention of heterosexually acquired HIV in men in settings where the prevalence of heterosexually transmitted HIV is high, with a focus on 15 countries in sub-Saharan Africa. These countries have established and rapidly scaled up VMMC within HIV programmes, and through 2019 over 27 million VMMCs were performed. The WHO 2020 VMMC Guidelines, and previous guidance documents, had identified reaching men at higher risk of HIV as a future priority for VMMC programme and research efforts. The 2020 guidance focused first on providing an up-to-date evidence summary on methods for enhancing uptake among adult men generally.
 
 
Resource | Guidelines
The PLHIV Stigma Index Implementation Guidelines: A handbook to support networks of people living with HIV to conduct the PLHIV Stigma Index 2.0. The Implementation Guidelines provide step-by-step guidance on all phases of implementation and link to many helpful templates and tools that can be used throughout the process. 
 
 
Resource | Guidelines
The programming guidelines aims to support organizations to implement programmes that address the realities and rights of YKP in Asia Pacific. The guidance provided herein is grounded in the experiences of a diversity of YKP and aims to introduce creativity, critical thinking and inspiration to the sector.
 
 
Resource | Guidelines
The objectives of these guidelines are to provide updated, evidence-informed clinical and practical recommendations on the case management of people with symptoms of STIs; and to support countries in updating their national guidelines for the case management of people with symptoms of STIs. These guidelines include the management of symptomatic infections related to urethral discharge syndrome, including persistent urethral discharge syndrome; vaginal discharge syndrome, including persistent vaginal discharge; anorectal infection; genital ulcer disease syndrome; and lower abdominal pain syndrome. These guidelines are intended for programme managers for STI prevention and control at the national level and the health-care providers at the frontline – primary, secondary and tertiary health care.
 
 
Resource | Guidelines
The World Health Organization (WHO) uses the following working definition of self-care: Self-care is the ability of individuals, families and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a health worker. The scope of self-care as described in this definition includes health promotion; disease prevention and control; self-medication; providing care to dependent persons; seeking hospital/specialist/primary care if necessary; and rehabilitation, including palliative care. It includes a range of self-care modes and approaches. While this is a broad definition that includes many activities, it is important for health policy to recognize the importance of self-care, especially where it intersects with health systems and health professionals.
 
 
Resource | Guidelines
These consolidated guidelines on HIV prevention, testing, treatment, service delivery  and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of the consolidated guidelines on HIV. These guidelines continue to be structured along the continuum of HIV care. Information on new combination prevention approaches, HIV testing, ARV regimens and treatment monitoring are included. There is a new chapter on advanced HIV disease that integrates updated guidance on the management of important HIV comorbidities, including cryptococcal disease, histoplasmosis and tuberculosis. The chapter on general HIV care, contains a new section on palliative care and pain management, and up to date information on treatment of several neglected tropical diseases, such as visceral leishmaniasis and Buruli ulcer. New recommendations for screening and treating of cervical pre-cancer lesions in women living with HIV are also addressed in this chapter.